Log in
Enquire now
‌

US Patent 9644036 Predictive marker for topoisomerase I inhibitors

Patent 9644036 was granted and assigned to Boston Medical Center on May, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Boston Medical Center
Boston Medical Center
0
Current Assignee
Boston Medical Center
Boston Medical Center
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
96440360
Patent Inventor Names
Ajit Bharti0
Date of Patent
May 9, 2017
0
Patent Application Number
146257210
Date Filed
February 19, 2015
0
Patent Primary Examiner
‌
Gary W Counts
0
Patent abstract

The present invention generally relates to phospho-serine 10 topoisomerase I antibodies and other protein binding moieties, and kits and uses thereof.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9644036 Predictive marker for topoisomerase I inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.